206 related articles for article (PubMed ID: 31959876)
1. CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual.
Yun Y; Hong SA; Kim KK; Baek D; Lee D; Londhe AM; Lee M; Yu J; McEachin ZT; Bassell GJ; Bowser R; Hales CM; Cho SR; Kim J; Pae AN; Cheong E; Kim S; Boulis NM; Bae S; Ha Y
Commun Biol; 2020 Jan; 3(1):33. PubMed ID: 31959876
[TBL] [Abstract][Full Text] [Related]
2. The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease.
Bakkar N; Starr A; Rabichow BE; Lorenzini I; McEachin ZT; Kraft R; Chaung M; Macklin-Isquierdo S; Wingfield T; Carhart B; Zahler N; Chang WH; Bassell GJ; Betourne A; Boulis N; Alworth SV; Ichida JK; August PR; Zarnescu DC; Sattler R; Bowser R
Neurobiol Dis; 2021 Feb; 149():105228. PubMed ID: 33359139
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
[TBL] [Abstract][Full Text] [Related]
4. In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
Gaj T; Ojala DS; Ekman FK; Byrne LC; Limsirichai P; Schaffer DV
Sci Adv; 2017 Dec; 3(12):eaar3952. PubMed ID: 29279867
[TBL] [Abstract][Full Text] [Related]
5. A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis.
Deneault E; Chaineau M; Nicouleau M; Castellanos Montiel MJ; Franco Flores AK; Haghi G; Chen CX; Abdian N; Shlaifer I; Beitel LK; Durcan TM
Methods; 2022 Jul; 203():297-310. PubMed ID: 34500068
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
7. The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model.
Duan W; Guo M; Yi L; Liu Y; Li Z; Ma Y; Zhang G; Liu Y; Bu H; Song X; Li C
Gene Ther; 2020 Apr; 27(3-4):157-169. PubMed ID: 31819203
[TBL] [Abstract][Full Text] [Related]
8. Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.
Long C; Amoasii L; Bassel-Duby R; Olson EN
JAMA Neurol; 2016 Nov; 73(11):1349-1355. PubMed ID: 27668807
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
10. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.
Bassuk AG; Zheng A; Li Y; Tsang SH; Mahajan VB
Sci Rep; 2016 Jan; 6():19969. PubMed ID: 26814166
[TBL] [Abstract][Full Text] [Related]
12. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
13. The role of de novo mutations in the development of amyotrophic lateral sclerosis.
van Doormaal PTC; Ticozzi N; Weishaupt JH; Kenna K; Diekstra FP; Verde F; Andersen PM; Dekker AM; Tiloca C; Marroquin N; Overste DJ; Pensato V; Nürnberg P; Pulit SL; Schellevis RD; Calini D; Altmüller J; Francioli LC; Muller B; Castellotti B; Motameny S; Ratti A; Wolf J; Gellera C; Ludolph AC; van den Berg LH; Kubisch C; Landers JE; Veldink JH; Silani V; Volk AE
Hum Mutat; 2017 Nov; 38(11):1534-1541. PubMed ID: 28714244
[TBL] [Abstract][Full Text] [Related]
14. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 guided rna based model for the treatment of Amyotrophic Lateral Sclerosis: A progressive neurodegenerative disorder.
Naveed M; Aqib Shabbir M; Aziz T; Hurraira HM; Fatima Zaidi S; Athar R; Chattha HA; Alharbi M; Alshammari A; Alasmari AF
Acta Biochim Pol; 2023 Sep; 70(3):643-653. PubMed ID: 37672770
[TBL] [Abstract][Full Text] [Related]
16. Long-read individual-molecule sequencing reveals CRISPR-induced genetic heterogeneity in human ESCs.
Bi C; Wang L; Yuan B; Zhou X; Li Y; Wang S; Pang Y; Gao X; Huang Y; Li M
Genome Biol; 2020 Aug; 21(1):213. PubMed ID: 32831134
[TBL] [Abstract][Full Text] [Related]
17. Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.
Min YL; Chemello F; Li H; Rodriguez-Caycedo C; Sanchez-Ortiz E; Mireault AA; McAnally JR; Shelton JM; Zhang Y; Bassel-Duby R; Olson EN
Mol Ther; 2020 Sep; 28(9):2044-2055. PubMed ID: 32892813
[TBL] [Abstract][Full Text] [Related]
18. Generation of gene-edited sheep with a defined Booroola fecundity gene (FecB
Zhou S; Yu H; Zhao X; Cai B; Ding Q; Huang Y; Li Y; Li Y; Niu Y; Lei A; Kou Q; Huang X; Petersen B; Ma B; Chen Y; Wang X
Reprod Fertil Dev; 2018 Nov; 30(12):1616-1621. PubMed ID: 31039970
[TBL] [Abstract][Full Text] [Related]
19. Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.
Zhou M; Hu Z; Qiu L; Zhou T; Feng M; Hu Q; Zeng B; Li Z; Sun Q; Wu Y; Liu X; Wu L; Liang D
Hum Gene Ther; 2018 Nov; 29(11):1252-1263. PubMed ID: 29598153
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS).
Kruminis-Kaszkiel E; Juranek J; Maksymowicz W; Wojtkiewicz J
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
